JPS634537B2 - - Google Patents
Info
- Publication number
- JPS634537B2 JPS634537B2 JP54133634A JP13363479A JPS634537B2 JP S634537 B2 JPS634537 B2 JP S634537B2 JP 54133634 A JP54133634 A JP 54133634A JP 13363479 A JP13363479 A JP 13363479A JP S634537 B2 JPS634537 B2 JP S634537B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- pyrido
- oxo
- propionic acid
- quinazolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782845766 DE2845766A1 (de) | 1978-10-18 | 1978-10-18 | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5557588A JPS5557588A (en) | 1980-04-28 |
| JPS634537B2 true JPS634537B2 (enrdf_load_stackoverflow) | 1988-01-29 |
Family
ID=6052696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13363479A Granted JPS5557588A (en) | 1978-10-18 | 1979-10-18 | Pyrido*2*11b**quinazolinone derivative*its manufacture and pharmacologically acting drug containing it |
Country Status (25)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3300477A1 (de) * | 1983-01-08 | 1984-07-12 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue heterocyclische verbindungen, ihre herstellung und verwendung |
| US4587339A (en) * | 1983-10-14 | 1986-05-06 | Sun Chemical Corporation | Nickel complex pigments of bis-azomethines |
| CZ281628B6 (cs) * | 1991-07-29 | 1996-11-13 | Warner-Lambert Company | Deriváty chinazolinu a farmaceutické přípravky na jejich bázi |
| US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
| CA2238283C (en) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
| US6410584B1 (en) * | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
| US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| US6130053A (en) * | 1999-08-03 | 2000-10-10 | Cell Pathways, Inc. | Method for selecting compounds for inhibition of neoplastic lesions |
| US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
| US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
| US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
| US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
| US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
| US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
| US6025394A (en) | 1999-01-29 | 2000-02-15 | Cell Pathways, Inc. | Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols |
| US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
| US6555547B1 (en) | 2000-02-28 | 2003-04-29 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative |
| US6569638B1 (en) | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1064259A (en) * | 1963-12-19 | 1967-04-05 | Union Pharma Scient Appl | New derivatives of 2-anilino-nicotinic acid and process for their preparation |
| US4033961A (en) * | 1975-10-07 | 1977-07-05 | Warner-Lambert Company | Pyrido[2-1-b]quinazolin-ones and their methods of preparation |
| DE2557425C2 (de) * | 1975-12-19 | 1987-03-19 | C.H. Boehringer Sohn, 6507 Ingelheim | 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
| US4066767A (en) * | 1976-11-01 | 1978-01-03 | Warner-Lambert Company | 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them |
| PH13915A (en) * | 1977-03-24 | 1980-11-04 | Hoffmann La Roche | Chinazoline derivatives |
-
1978
- 1978-10-18 DE DE19782845766 patent/DE2845766A1/de not_active Withdrawn
-
1979
- 1979-10-11 NZ NZ191828A patent/NZ191828A/xx unknown
- 1979-10-15 EP EP79103974A patent/EP0011142B1/de not_active Expired
- 1979-10-15 DE DE7979103974T patent/DE2964431D1/de not_active Expired
- 1979-10-15 DD DD79216232A patent/DD147242A5/de unknown
- 1979-10-15 AT AT79103974T patent/ATE2146T1/de not_active IP Right Cessation
- 1979-10-16 RO RO7998984A patent/RO78339A/ro unknown
- 1979-10-16 PL PL1979227126A patent/PL123075B1/pl unknown
- 1979-10-16 PL PL1979227124A patent/PL123430B1/pl unknown
- 1979-10-16 GR GR60275A patent/GR73819B/el unknown
- 1979-10-16 PL PL1979218993A patent/PL119174B1/pl unknown
- 1979-10-16 AU AU51832/79A patent/AU529643B2/en not_active Expired - Fee Related
- 1979-10-17 SU SU792832051A patent/SU1001857A3/ru active
- 1979-10-17 IE IE1969/79A patent/IE48852B1/en unknown
- 1979-10-17 DK DK438379A patent/DK154297C/da active
- 1979-10-17 NO NO793344A patent/NO793344L/no unknown
- 1979-10-17 PT PT70329A patent/PT70329A/pt unknown
- 1979-10-17 IL IL58474A patent/IL58474A0/xx unknown
- 1979-10-17 CA CA337,796A patent/CA1130805A/en not_active Expired
- 1979-10-18 EG EG624/79A patent/EG14028A/xx active
- 1979-10-18 ES ES485162A patent/ES8103745A1/es not_active Expired
- 1979-10-18 JP JP13363479A patent/JPS5557588A/ja active Granted
- 1979-10-18 ZA ZA00795559A patent/ZA795559B/xx unknown
- 1979-10-18 GB GB7936147A patent/GB2034705B/en not_active Expired
- 1979-10-18 FI FI793229A patent/FI793229A7/fi not_active Application Discontinuation
- 1979-10-18 CS CS797083A patent/CS216512B2/cs unknown
- 1979-10-18 FR FR7925883A patent/FR2439199A1/fr not_active Withdrawn
-
1982
- 1982-12-22 US US06/452,009 patent/US4457927A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS634537B2 (enrdf_load_stackoverflow) | ||
| US4066651A (en) | Alkanoic acid 2-quinoline derivatives | |
| JPS63230687A (ja) | カルボスチリル誘導体 | |
| WO2001079197A1 (en) | ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ) | |
| US4166851A (en) | Certain imidazo(1,2a)pyridine derivatives | |
| US4408047A (en) | Imidazodiazines | |
| JPH0390063A (ja) | 二置換された（キノリン―２―イル―メトキシ）フエニル酢酸誘導体 | |
| US7309718B2 (en) | Dibenzocycloheptene compound | |
| JP4241970B2 (ja) | アミド結合を有するインドール誘導体、及びモノ又はジアザインドール誘導体 | |
| US4845100A (en) | Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same | |
| CN107922375A (zh) | 靶向idh2突变的抗肿瘤化合物及其使用方法 | |
| JPS60208980A (ja) | チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤 | |
| JPS6019317B2 (ja) | チエノチアジン誘導体及びその製造方法 | |
| JP4294469B2 (ja) | Ｐｄｅｉｖ阻害剤 | |
| JPS60260577A (ja) | １，８−ナフチリジン誘導体 | |
| JP2003505449A (ja) | １−（６−メチルピリジン−３−イル）−２−［４−（メチルスルホニル）フェニル］エタノンの製造方法 | |
| JPH0710873A (ja) | インドリジン誘導体その製造法および中間体としての使用 | |
| KR910000443B1 (ko) | 할로알킬 티아졸의 제조방법 및 이 방법으로 제조한 할로알킬 티아졸 | |
| US4330543A (en) | Imidazoazines and imidazodiazines | |
| JPH01157955A (ja) | 新規複素環誘導体およびその製造法 | |
| WO2004058742A1 (ja) | ベンゾシクロヘプタピリジン化合物 | |
| IE52890B1 (en) | Pyridothienopyridazine compounds | |
| US4187310A (en) | 1,2-Dihydro-2-oxoquinol-4-ylacetic acid derivatives and pharmaceutical compositions | |
| JPH07500102A (ja) | 医薬用ピリジノール誘導体 | |
| HU196997B (en) | Process for producing pyridine derivatives and pharmaceuticals comprising these compounds as active ingredient |